Combined Alcohol Exposure and KRAS Mutation in Human Pancreatic Ductal Epithelial Cells Induces Proliferation and Alters Subtype Signatures Determined by Multi-Omics Analysis
Pancreatic Ductal adenocarcinoma (PDAC) is an aggressive cancer commonly exhibiting KRAS-activating mutations. Alcohol contributes to the risk of developing PDAC in humans, and murine models have shown alcohol consumption in the context of KRAS mutation in the pancreas promotes the development of PD...
Main Authors: | Emalie J. Clement, Henry C.-H. Law, Fangfang Qiao, Dragana Noe, Jose G. Trevino, Nicholas T. Woods |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-04-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/14/8/1968 |
Similar Items
-
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
by: Enrico Gurreri, et al.
Published: (2023-05-01) -
Targeting KRAS in Pancreatic Ductal Adenocarcinoma: The Long Road to Cure
by: Victor Hugo Fonseca de Jesus, et al.
Published: (2023-10-01) -
Genomic landscape of clinically advanced KRAS wild-type pancreatic ductal adenocarcinoma
by: Prashanth Ashok Kumar, et al.
Published: (2023-06-01) -
Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer
by: April Lo, et al.
Published: (2022-12-01) -
Light at the end of the tunnel: Clinical features and therapeutic prospects of KRAS mutant subtypes in non-small-cell lung cancer
by: Liyuan Gao, et al.
Published: (2022-10-01)